Effect of the Stellate Ganglion Block on the Retinal Microcirculation
1 other identifier
observational
50
1 country
1
Brief Summary
Surges in the sympathetic nervous system occur at the ictus of a variety of neurological critical illnesses including intracranial hemorrhage and ischemic stroke. It is hypothesized that these exaggerated increases in sympathetic nervous activity produce maladaptations that promote secondary brain injury. One of these possible mechanisms include diffuse vasospasm that cause cerebral ischemia. Hence, methods to abrogate the sympathetic nervous system in this context are under active investigation. One possible method is the regional anesthesia technique of the stellate ganglion nerve block, which is ordinarily used for complex regional pain syndrome, but has been shown to reduce cerebral sympathetic activity and reduces vasospasm in patients with subarachnoid hemorrhage. However, its effect on the microcirculation is not clear. Hence, we propose to study patients receiving the stellate ganglion nerve block as part of their standard medical care and to image their retinal microcirculation before and after the procedure using Optical Coherence Tomography Angiography (OCTA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 7, 2024
CompletedFirst Submitted
Initial submission to the registry
December 21, 2024
CompletedFirst Posted
Study publicly available on registry
January 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 7, 2026
November 19, 2025
November 1, 2025
2 years
December 21, 2024
November 15, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Vascular and Perfusion Density
Quantitative measure of retinal microperfusion
One day
Study Arms (1)
Intervention Group
Patients receiving the stellate ganglion block
Interventions
Optical Coherence Tomography Angiography before and after receiving the stellate ganglion nerve block.
Eligibility Criteria
Patients receiving the stellate ganglion block
You may qualify if:
- Age 18 years or older
- Patients receiving the stellate ganglion nerve block for an approved indication, e.g. complex regional pain syndrome
You may not qualify if:
- Pregnancy
- Non-English speaking
- Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT Southwestern Medical Center
Dallas, Texas, 75235, United States
Related Publications (1)
Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005 Apr;206(4):319-48. doi: 10.1111/j.1469-7580.2005.00395.x.
PMID: 15817102BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noah Jouett, DO, PhD
University of Texas Southwestern Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 21, 2024
First Posted
January 28, 2025
Study Start
October 7, 2024
Primary Completion (Estimated)
October 7, 2026
Study Completion (Estimated)
October 7, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Pilot study